John M. Goldman

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Journal: British journal of haematology

Published: October 15, 2021

Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.

Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.

Journal: Bone marrow transplantation

Published: January 23, 2020

Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.

Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.

Journal: Haematologica

Published: May 03, 2014

Chronic myeloid leukemia in India.

Chronic myeloid leukemia in India.

Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Published: February 12, 2014

History of chronic myeloid leukemia: a paradigm in the treatment of cancer

History of chronic myeloid leukemia: a paradigm in the treatment of cancer

Journal: Bulletin du cancer

Published: February 05, 2014

Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects.

Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects.

Journal: British journal of haematology

Published: November 14, 2013

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Journal: The New England journal of medicine

Published: November 05, 2013

What does MRD in leukemia really mean?

What does MRD in leukemia really mean?

Journal: Leukemia

Published: October 31, 2013

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.

Journal: Blood

Published: August 24, 2013

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

Journal: Blood

Published: August 09, 2013

What challenges remain in chronic myeloid leukemia research?

What challenges remain in chronic myeloid leukemia research?

Journal: Haematologica

Published: August 02, 2013

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Journal: Blood

Published: June 28, 2013

Showing 1-12 of 47

Last Updated: 09/26/2026